Media-OutReach Newswire AIM Vaccine submitted the pre-application for clinical trials for novel-process highly-effective human diploid rabies vaccine
Media-OutReach Newswire Regenerative approach essential to align sustainability ambition and action in Asia Pacific’s growing economy: Kearney
Media-OutReach Newswire ZJLD Group Recorded Revenue of more than RMB7 Billion for FY2023 Annual Results
Opinion Pharmaceutical milestones: 250 million doses of vaccines and enhanced legal framework amid COVID-19